Analysts Set Myriad Genetics, Inc. (NASDAQ:MYGN) Price Target at $20.61
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have earned an average recommendation of “Hold” from the sixteen analysts that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company. […]
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have earned an average recommendation of “Hold” from the sixteen analysts that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company. […]
